ArticleClinical drug investigation2020
Post-approval Safety Monitoring of Quadrivalent and Bivalent Human Papillomavirus Vaccines Based on Real-world Data from the Korea Adverse Events Reporting System (KAERS).
MoonJung Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.